🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

For those who want to read it! ⁦ECOG-ACRIN Cancer Research Group⁩ ⁦ASCO⁩ ⁦American College of Radiology⁩ #TMIST

Excited to share FoRtitude results! Grateful for collaboration with 3 NCI Community Oncology Research Program sites to enroll geographically diverse sample of women from community oncology practices. FoRtitude 2.0 in development through ECOG-ACRIN Cancer Research Group

PRO researchers everywhere are cheering! Fantastic support for the critical role of patient-rated symptoms to ensure high quality cancer care

You're on, @mroth_MD!

Great work Rebecca Erwin Wells, MD, MPH, FAHS, FAAN! Wake Forest University School of Medicine

.Lynne I Wagner PhD @GyasiSamilia

If you are between the ages of 18-39 & have cancer (any stage you may be eligible for a research study that aims to address individuals’ needs related to post-treatment problems. More: bit.ly/EAQ202 cc: John M. Salsman, Lynne I Wagner PhD, Ruth Carlos, Stupid Cancer

Happy fall Chicagoans! I miss this view

“We will work together to reinvent how we approach, design, and conduct #clinicaltrials, and report results.” - Dr. Kimryn Rathmell Thank you for joining us last night & sharing your vision for the future of #CancerResearch! More: bit.ly/3FsgGvB

I was honored to join Dr. Kimryn Rathmell during ECOG-ACRIN Cancer Research Group Group meeting to celebrate Dr. Worta McCaskill-Stevens' leadership and accomplishments in #NCORP to reduce #cancerdisparities and improve #clinicaltrial access National Cancer Institute @NCIprevention Wake Forest University School of Medicine Atrium Health Wake Forest Baptist @NCISymptomMgmt

#Clinicaltrial EA8184, led by Dr. Nagi Kumar of Moffitt Cancer Center will evaluate if #greentea catechins can help prevent the progression of #prostatecancer in men on active surveillance. Learn more here: bit.ly/ea8184trial #pcsm cc: juan luis pow sang campos

Exciting research led by colleague Stephanie Sohl! Stephanie J. Sohl

Lynne I. Wagner – Childhood Cancer Researcher cancer.gov/research/areas… Grateful for opportunity to share my story and why I'm passionate about #patientreportedoutcomesresearch! And for wonderful #AYA collaborators John M. Salsman Brad Zebrack @mroth_MD Wake Forest Baptist - Comprehensive Cancer Center ECOG-ACRIN Cancer Research Group National Cancer Institute

So excited to see all that you'll accomplish! Your fans across #NCTN, #NCORP and ECOG-ACRIN Cancer Research Group are cheering for you!

If you are between the ages of 18-39 & have cancer (any stage you may be eligible for a research study that aims to address individuals’ needs related to post-treatment problems. More: bit.ly/EAQ202 cc: John M. Salsman, Lynne I Wagner PhD, Ruth Carlos, Stupid Cancer

Hilarious and painfully true!

1st large racially diverse study to evaluate genetic predictors of aromatase inhibitor-associated musculoskeletal symptoms in early #breastcancer. E1Z11 results in Clinical Cancer Research Congrats to Vered Stearns Lynne I Wagner PhD et al ECOG-ACRIN Cancer Research Group National Cancer Institute #NCORP tinyurl.com/E1Z11-results

Check out Journal of Clinical Oncology Podcast: "EAZ171: Predictors of TIPN in Black women with #BreastCancer" w/ Dr. Shannon Westin, MD, MPH, FASCO & Dr. Bryan Schneider. EAZ171 was presented at the #ASCO24 Annual Meeting. Tarah Ballinger, MD @NCIprevention #NCORP Susan G. Komen Vera Bradley Foundation jcopodcast.libsyn.com/eaz171-predict…

In press! Check out our new publication focused on the overlap between #insomnia and #fearofrecurrence in #cancer — exploratory findings from our team’s pilot RCT MGH HPRIR Mongan Institute MGH Psychiatry Mass General Cancer Center

The EAQ211/The AYA Social Genomics Study clinical study is evaluating the impact of social and genetic factors on outcomes in adolescent & young adult (#AYA) #cancer survivors. Learn more: bit.ly/eaq211-study #AYACancer #AYACSM